1. Home
  2. IPW vs VRAX Comparison

IPW vs VRAX Comparison

Compare IPW & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iPower Inc.

IPW

iPower Inc.

N/A

Current Price

$1.33

Market Cap

1.1M

ML Signal

N/A

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$0.79

Market Cap

972.3K

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IPW
VRAX
Founded
2018
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1M
972.3K
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
IPW
VRAX
Price
$1.33
$0.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.7M
413.3K
Earning Date
11-17-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $19,956,938.00
N/A
Revenue This Year
$596.00
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.18
$0.10
52 Week High
$2,019,375,000.00
$13.19

Technical Indicators

Market Signals
Indicator
IPW
VRAX
Relative Strength Index (RSI) 25.36 22.68
Support Level $0.18 $0.15
Resistance Level $1.57 $3.01
Average True Range (ATR) 0.31 0.17
MACD 19.09 0.00
Stochastic Oscillator 36.22 15.95

Price Performance

Historical Comparison
IPW
VRAX

About IPW iPower Inc.

iPower Inc is a technology-enabled commerce infrastructure company providing supply chain, logistics, fulfillment, warehousing and procurement solutions for e-commerce and distribution channels. Its product portfolio includes hydroponic products, gardening supplies, home goods and related accessories, with gardening and home products. Geographically, the company generates majority of its revenue from the United States, followed by Canada and other international markets.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Share on Social Networks: